Jul 8, 2026 07:01AM
Jul 8, 2026 07:01AM
Jun 1, 2026 08:00AM
Jun 1, 2026 08:00AM
May 11, 2026 04:01PM
May 4, 2026 06:01AM
May 4, 2026 06:01AM Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
Mar 31, 2026 06:43AM
Mar 30, 2026 07:00AM
Nov 20, 2025 08:00PM
Nov 20, 2025 08:00PM
Nov 13, 2025 07:00AM
Aug 13, 2025 07:00AM
May 28, 2025 06:45AM H.C. Wainwright Assumes Aura Biosciences (AURA) at Buy
May 23, 2025 04:09AM
May 15, 2025 06:01AM
Apr 2, 2025 07:03AM
Apr 2, 2025 07:00AM
Mar 25, 2025 06:48AM
Mar 24, 2025 04:01PM
Mar 4, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Aura Biosciences (AURA)
Mar 3, 2025 07:01AM
Mar 3, 2025 07:00AM
Nov 12, 2024 04:05PM
Oct 18, 2024 08:17AM
Sep 13, 2024 06:43AM
Sep 12, 2024 06:30AM
Sep 12, 2024 06:30AM Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma
Sep 3, 2024 04:05PM
Aug 26, 2024 04:05PM
Aug 8, 2024 07:00AM
May 23, 2024 08:00AM
May 9, 2024 07:00AM
Mar 27, 2024 07:00AM
Dec 7, 2023 08:00AM Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal
Nov 9, 2023 04:05PM
Nov 6, 2023 03:00PM
Nov 6, 2023 03:00PM
Aug 9, 2023 07:00AM
May 11, 2023 04:10PM
Mar 15, 2023 04:10PM
Nov 10, 2022 07:00AM Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
Oct 4, 2022 07:06AM
Oct 4, 2022 07:05AM
Oct 3, 2022 07:03AM
Oct 3, 2022 07:00AM
Sep 28, 2022 07:00AM
Aug 11, 2022 04:15PM
Jun 30, 2022 07:01AM Aura Biosciences (AURA) Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer
Jun 30, 2022 07:00AM

326,424 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All